Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from aspirepeptides.com, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | NMR | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|---|
| GLOW (BPC-157; GHK-Cu; TB-500 blend) | 1 | 99.99% | — | — |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
| Peptide | Lot | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| Retatrutide | RT20-032026-1 | ILS Labs | 99.86% | LALUSP<71>HM | 2026-07-08 | View |
| Tirzepatide | TR10-032026-1 | ILS Labs | 99.22% | LALUSP<71>HM | 2026-07-08 | View |
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| — |
| Retatrutide | 3 | 99.79% | — | — | — |
| Tirzepatide | 3 | 99.65% | — | — | — |
| Retatrutide |
| RT15-032026-1 |
| ILS Labs |
| 99.78% |
| LALUSP<71>HM |
| 2026-07-07 |
| View |
| Retatrutide | GLP-3R | ILS Labs | 99.72% | LALUSP<71>HM | 2026-07-07 | View |
| Tirzepatide | TR15-032026-1 | ILS Labs | 99.81% | LALUSP<71>HM | 2026-07-07 | View |
| GLP-2T (Tirzepatide) | TR20-032026-1 | ILS Labs | 99.92% | LALUSP<71>HM | 2026-07-07 | View |
| GLOW (BPC-157; GHK-Cu; TB-500 blend) | BBG70-052026-1 | AccumarkLabs | 99.99% | LALUSP<71>HM | 2026-07-05 | View |
Disclosed Labs